Mutations in FOXP2, a member of the forkhead family of transcription factor genes, are the only known cause of developmental speech and language disorders in humans. To date, there are no known targets of human FOXP2 in the nervous system. The identification of FOXP2 targets in the developing human brain, therefore, provides a unique tool with which to explore the development of human language and speech. Here, we define FOXP2 targets in human basal ganglia (BG) and inferior frontal cortex (IFC) by use of chromatin immunoprecipitation followed by microarray analysis (ChIP-chip) and validate the functional regulation of targets in vitro. ChIP-chip identified 285 FOXP2 targets in fetal human brain; statistically significant overlap of targets in BG and IFC indicates a core set of 34 transcriptional targets of FOXP2. We identified targets specific to IFC or BG that were not observed in lung, suggesting important regional and tissue differences in FOXP2 activity. Many target genes are known to play critical roles in specific aspects of central nervous system patterning or development, such as neurite outgrowth, as well as plasticity. Subsets of the FOXP2 transcriptional targets are either under positive selection in humans or differentially expressed between human and chimpanzee brain. This is the first ChIP-chip study to use human brain tissue, making the FOXP2-target genes identified in these studies important to understanding the pathways regulating speech and language in the developing human brain. These data provide the first insight into the functional network of genes directly regulated by FOXP2 in human brain and by evolutionary comparisons, highlighting genes likely to be involved in the development of human higher-order cognitive processes. 
Spoken language and written language are uniquely human traits with a significant but complex genetic component. As with other developmental processes, the study of rare Mendelian forms of language or speech disorders provides an efficient means to begin to understand the molecular basis of human speech and language.
1 FOXP2 was identified as involved in speech and language when affected members of the "KE" family were found to carry a mutated allele, and an unrelated individual was found to carry a balanced translocation with a break in FOXP2 2 (causing speech-language disorder 1 [SPCH1 {MIM 602081}]). Its role in speech and language was reiterated when an additional mutation that caused a truncation of FOXP2 was identified in a family with speech and language deficits. 3 Individuals with FOXP2 mutations have dominantly inherited verbal dyspraxia and linguistic and/ or grammatical difficulties. 2, 4, 5 Additionally, patients with FOXP2 mutations have demonstrated developmental abnormalities of the basal ganglia (BG) and inferior frontal cortex (IFC). 6, 7 FOXP2 expression overlaps with perisylvian frontal and temporal regions, including the inferior frontal gyrus (Broca's region), but also extends more broadly to suggest a role in complex sensory motor integration involving auditory vocal learning, 8, 9 as well as mirror neuron system function, which is highly evolved in primates and disrupted in autism. 10, 11 FOXP2 belongs to a family of proteins that contain a forkhead DNA binding, or "winged helix," domain, a region responsible for DNA binding that is found in transcription factors.
2 FOXP2 also contains a transcriptional repression domain including a zinc-finger motif in the Nterminal region 12 and has been shown to interact with the corepressor protein C-terminal binding protein 1. 13 Foxp1, Foxp2, and Foxp4 have been demonstrated to form hetero-and homotypic dimers that are important for their transcriptional activity. 13 The expression patterns of FOXP1 and FOXP2 are not identical 8 ; therefore, in some cases, the proteins may be forming heterotypic dimers, whereas, in others, they may act alone. 13 Foxp2, the mouse orthologue of FOXP2, has been proposed to be an important regulator of proximal versus distal epithelial differentiation in the lung, on the basis of in vitro repression of the mouse CC10 promoter and human SP-C promoter. 12 Additionally, other members of the forkhead-box (FOX) family of transcription factors are well established as transcriptional repressors or activators involved in development. [14] [15] [16] However, the role of FOXP2 in the brain and its transcriptional targets remain to be elucidated. Protein from MRC5 cells transfected with expression vectors containing FOXP2 isoforms I and III and FOXP1 and FOXP4 transcripts were run on an SDS-PAGE gel, were transferred to PVDF membrane, and were hybridized with polyclonal anti-FOXP2 antibody (lanes [1] [2] [3] [4] . FOXP1 and FOXP4 were also hybridized with protein-specific antibodies (lanes 5 and 6) as a positive control for protein expression. B, FOXP2 isoform I protein immunoprecipitated from lung, BG, and IFC regions run on an SDS-PAGE gel, transferred to PVDF membrane, and hybridized with polyclonal anti-FOXP2 antibody (Ab).
Previous analyses of amino acid changes in FOXP2 across species indicate that FOXP2 has undergone accelerated evolution in humans. 17, 18 The most parsimonious explanation for the observed acceleration is positive selection of FOXP2 in humans, since there is no evidence of an increase in the mutation rate or purifying selection. Thus, the study of FOXP2 provides a potentially powerful avenue for investigations into the molecular and physical adaptations that allowed for the development of speech and language in humans. Language is a complex trait and necessarily involves the interaction of many genes, 1 some of which may have coevolved. Since FOXP2 is a transcription factor, identification of its transcriptional targets in the brain and the assessment of their evolution would provide an important advance by elucidating the molecular pathways involved and potential evidence of their adaptive evolution.
Here, using chromatin immunoprecipitation (ChIP) followed by hybridization of the precipitated DNA to human promoter arrays (hereafter, "ChIP-chip"), we have identified targets of FOXP2 in vivo in both the BG region and the IFC of the human fetal brain. A subset of ChIP-chipidentified targets were confirmed by ChIP-quantitative PCR, and the functional consequence of FOXP2 binding to target promoters was demonstrated by FOXP2 overexpression in vitro. This study, along with that by Vernes et al., 19 (in this issue) provides the first insight into the direct functional targets of FOXP2 during human brain development, as well as a core set of genes for further exploration into the genetic basis of human speech and language.
Material and Methods

Antibody Production
A 15-mer amino acid sequence was chosen from the C-terminal region of FOXP2. A FOXP2 antibody was made against the 14-aa sequence EDLNGSLDHIDSNG ( fig. 1 ) in the C-terminal region of FOXP2. The 14-aa peptide was chosen on the basis of its antigenicity (DNASTAR) and dissimilarity between family members FOXP1 and FOXP4 ( fig. 1) . Similarity of the amino acid sequence to other proteins was excluded by comparisons with family members FOXP1 and FOXP4, as well as by protein blast (blastp) analysis (BLAST). The peptide was conjugated to keyhole limpet hemocyanin, and rabbits were immunized with the peptide and complete Freund's adjuvant (Sigma-Genosys). Antibody was purified on an affinity purification column with the peptide (SigmaGenosys).
Western-Blot Analysis
MRC5 or SH-SY5Y cells were lysed in hypotonic buffer (10 mM Tris-Cl, 10 mM KCl, 0.1 mM EDTA, and 0.1 mM ethylene glycol tetraacetic acid [EGTA] ) and were sonicated briefly. Cell debris was removed by centrifugation. Protein was run on a 7.5% SDS-PAGE gel and was transferred to a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked with 5% milk in PBSTween for 2 h. The corresponding lanes were then incubated with FOXP2 in-house antibody (1:5,000 dilution), FOXP1 in-house antibody (1:10,000 dilution), FOXP4 ab17726 Abcam antibody (1: 1,000 dilution), or FLAG F3165 Sigma antibody (1:10,000 dilution) in 5% milk in PBS-Tween overnight at 4ЊC. Blots were washed and incubated with 1:10,000 dilution of horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibody (Jackson ImmunoResearch Laboratories) and then were ex-posed to SuperSignal West Pico Chemiluminescent Substrate (Pierce) in accordance with the manufacturer's directions. (16) (17) (18) (19) (20) were investigated because this time corresponds to the peak period of neuronal migration, differentiation, and cortical regionalization and is a time of high FOXP2 expression. 8, 9, 20 ChIP ChIP was performed as described elsewhere. 21 For each experiment, 0.6 g of human tissue was used. Tissue was finely minced in PBS on ice, and the cross-linking reaction was subsequently performed for 15 min at room temperature. Nuclei were isolated, and DNA was sonicated in 1 ml of buffer (1 mM EDTA, 0.5 mM EGTA, and 10 mM Tris-HCl) to DNA fragments that were ∼0.2-1 kb in size. Then, 100 ml of Protein A beads were mixed with 10 mg of FOXP2 antibody overnight. Nuclear lysate was hybridized to the beads overnight. Beads were then washed five times with RIPA buffer (50 mM Hepes, 1 mM EDTA, 0.7% deoxycholic acid, 1% NP-40, and 0.5 M LiCl), and protein-DNA complexes were eluted (50 mM Tris, 10mM EDTA, and 1% SDS) at 65ЊC for 12 min. The cross-linking reaction was reversed at 65ЊC overnight (50 mM Tris, 10 mM EDTA, and 1% SDS). The ends of the DNA were blunted with T4 DNA polymerase (New England Biolabs) for 20 min at 12ЊC. DNA was ligated to annealed linkers (oJW102, GCGGTGACCCGGGAGATCTGAATTC, and oJW103, GAATTCA-GATC) at 16ЊC for 16 h. ChIP and input DNA were amplified by PCR, with 1 mM deoxynucleotide triphosphates, 2 U Taq (Qiagen), and 1 mM oJW102. Cycling conditions were 1 cycle for 5 min at 72ЊC; 95ЊC for 2 min; 24 cycles at 95ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 1 min; and 1 cycle for 5 min at 72ЊC. For some ChIPs, a second and third round of PCR was performed to obtain enough DNA.
Tissue Samples
Labeling and Hybridization
A total of 200 ng of purified PCR product was labeled with Cy5 (ChIP DNA) and Cy3 (input DNA) with BioPrime DNA labeling system (Invitrogen) at 37ЊC for 16 h. Human promoter arrays (Aviva Systems Biology) 22 were hybridized with 2 mg of each labeled ChIP and input DNA.
Microarray and Data Analysis
Arrays were scanned on a GenePix 4000B (Molecular Devices), and image analysis was performed with GenePix Pro 6.0. Three independent biological replicates were analyzed for BG and IFC; two independent biological replicates were analyzed for lung. Poor-quality spots were flagged by GenePix Pro 6.0. Background was determined on a spot-by-spot basis. Data analysis was performed using R with Bioconductor 23 packages Limma and Marray. The quality of arrays was determined on the basis of signal plots before normalization. Spots whose signal intensities were twofold greater than the local background were considered present. Median normalization was performed. Data have been deposited into NCBI Gene Expression Omnibus (GEO) and can be accessed with accession number GSE8547.
Gene Ontology (GO) Analysis
Target genes with an M score 10.5 and a P value of 1.05 were analyzed using DAVID. 24, 25 The Fisher exact test was used, with all array genes as background.
Stable and Transient-Overexpression Cell Lines
cDNA was transcribed from RNA isolated (Qiagen) from human fetal brain by use of the Superscript First-Strand Synthesis System (Invitrogen). FOXP2 was amplified via PCR with forward primer FOXP2-1F(BamHI)ϩ (5 -aaggatccatgatgcaggaatctgcgac-3 ) and reverse primer FOXP2-1R(EcorI)ϩ (5 -ccgaattcttccagatcttcagataaaggc-3 ). FOXP1 was amplified with forward primer Foxp1kozakF 
Real-Time PCR
RNA was extracted using RNeasy Mini Kit (Qiagen) following the manufacturer's directions. DNA was removed by digestion with RNase-free DNase (Qiagen). A quantity of 1.2-5 mg was used in a reaction to synthesize cDNA with oligo dT primers. Quantitative real-time PCR was performed on an ABI 7900HT (Applied Biosystems) with SDS 2.1 software. The reaction mix contained iTaq SYBR Green Supermix (Bio-Rad) and 0.3 mM of each primer. Cycling conditions were 50ЊC for 2 min and 95ЊC for 3 min, followed by 45 cycles at 95ЊC for 15 s and 58ЊC for 45 s, and, finally, 95ЊC for 15 s, 60ЊC for 20 s, and 95ЊC for 15 s.
ChIP-PCR
ChIP was done as described above by use of anti-FOXP2 (rabbit polyclonal [Abcam]) or anti-FLAG (mouse monoclonal [Sigma]) antibodies. PCR was performed using either SYBR Green Supermix (Bio-Rad) or Taq (Qiagen) and the following primers: for ANK1, 5 -ccccctccttaggaaacaaa-3 and 5 -agcccagagttggacatcag-3 ; for CALCRL, 5 -tcactctttcccaccttgct-3 and 5 -gaaacattgccaaactatatgagaa-3 ; for CDH1, 5 -ctcgacacccgattcaaagt-3 and 5 -gcgtgactttggtggaaaac-3 ; for LBR, 5 -taaagctgggaggtgctgtc-3 and 5 -ggctgctgtaggcttgagag-3 ; for KCNJ15, 5 -ccagtaggcaaatccttcca-3 and 5 -ggggatagaaattcgggtgt-3 ; for PIR51, 5 -cagtccaagtgcccctatgt-3 and 5 -ggaactacccacctcacagg-3 ; for PPP2R1B, 5 -acaacagaaggcaccattcc-3 and 5 -ccgctcagactcaaacttcc-3 ; for TGM2, 5 -tggctgtgtcaggctgtatc-3 and 5 -acacagagagcagacgcaga-3 ; and, for TNNI1, 5 -tgctggtttcactcagttgg-3 and 5 -aatgcacacaacaggcacat-3 .
Table 1. Summary of Results for All Identified Target Genes
The table is available in its entirety in the online edition of The American Journal of Human Genetics.
Comparison of Gene-Expression Levels and Estimates of Protein-Sequence Divergence Rates between Humans and Chimpanzees
Gene-expression levels in human and chimpanzee cerebral cortex were determined by combining microarray data from three independent studies. [26] [27] [28] To identify probes common to both species, megablast (BLAST) was used to align all probes from the Affymetrix HGU95Av2 microarray to the human genome (build 34) and the chimpanzee draft genome. Any probe without a perfect match in both species (∼1/4) was masked during the calculation of expression values (GCOSv1.2 [Affymetrix]). In addition, only probe sets with six or more matching probes were retained for subsequent analyses ( of 12,625 sets). For each arn p 11,768 ray, expression values were scaled to an average intensity of 200 (GCOSv1.2 [Affymetrix]). Two samples, "Hs3_MFG" and "Pt4_FP" from the study of Caceres et al., 26 were identified as outliers and were removed from the analysis. Technical replicates were averaged, followed by biological replicates (i.e., different cortical samples from the same individual). After averaging, there were 11 unique human and 8 unique chimpanzee individuals in the data set (two of the chimpanzees from these studies [26] [27] [28] were identical). Quantile normalization 26 was then performed, and data were log transformed. Gene-expression levels were compared between the species by use of a Bayesian t test via the "bayesreg" R package, with the settings betaFit p 1, winSize p 101, and conf p 10. Estimated rates of protein-sequence divergence between humans and chimpanzees were obtained from the study of Khaitovich et al.
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Results
The FOXP subfamily of transcription factors have relatively high homology among themselves, so it was important to generate an immunoreagent that would meet the specificity and efficiency requirements of ChIP. We produced a high-affinity FOXP2 polyclonal antibody on the basis of immunization with a relatively divergent region near the C-terminus ( fig. 1 ). Since isoform III does not share the N-terminus with isoforms I and II, this Cterminal moiety provided the additional benefit of permitting detection of all FOX domain-containing isoforms of FOXP2. No cross-reactivity was detected for FOXP1 or FOXP4, and the antibody detected two major FOXP2 isoforms, designated isoform I and III (GenBank accession numbers NP_055306 and NP_683697 or NP_683698) as predicted ( fig. 1) . A protein of ∼80 kDa was immunoprecipitated from human fetal brain regions and lung ( fig. 1 ). Immunohistochemistical staining of mouse brain by use of this antibody reflects previously described patterns of postmitotic neuronal staining in the cortex and BG (data not shown). 20 
Identification of Core FOXP2 Targets by In Vivo ChIP-Chip in Fetal Human Brain
Given previous data suggesting adaptive evolution of FOXP2 in humans 17, 18 and its involvement in human higher cognitive functions, we were interested in elucidating FOXP2 targets in the human brain. We performed ChIP-chip experiments on human fetal brain during midgestation, which corresponds to the peak period of neuronal migration, differentiation, and cortical regionalization and is a time of high FOXP2 expression. 8, 9, 20 The two regions we chose, one cortical (IFC) and one subcortical (BG), are part of a parallel-distributed circuitry that, among other functions, is involved in language and speech, 30, 31 express high levels of FOXP2 during this period of development, 8 and are sites of abnormalities in patients with FOXP2 mutations. 32 Thus, FOXP2 targets identified within these regions during human brain development would be particularly germane to the understanding of the molecular circuitry involved in the development of these regions and their relationship to speech and language functions. Furthermore, the importance of this period for key aspects of the development of the human cerebral cortex is also highlighted by previous studies that demonstrate key elements of patterning-including brain asymmetry, a structural correlate of language-that occur during this time. 31, 33 We used rapidly frozen tissue stored at Ϫ80ЊC, with short postmortem intervals, to optimize the likelihood of detecting regions of DNA bound by FOXP2 (see the "Material and Methods" section). ChIP products from three independent replicates were hybridized onto Aviva Systems Biology cDNA promoter arrays containing ∼6,000 DNA fragments from potential regulatory regions, which were initially validated in the first genomewide ChIP-chip studies (see the "Material and Methods" section). 22 Although this is not a whole-genome microarray, it has been validated in several important ChIP studies and provides a very solid cross-section of genes. 34, 35 Since no FOXP2 targets had been previously identified, we reasoned that this platform would provide a good cross-section of targets.
We identified 175 targets in BG and 144 targets in IFC, using conservative criteria (see the "Material and Methods" section and table 1). The overlap between the two regions was highly significant, with 24% of IFC genes overlapping with BG genes (hypergeometric probability p !
). An additional set of genes identified as re-
Ϫ22
6.767 # 10 gionally specific in either BG (141 genes) or IFC (110 genes) were identified ( fig. 2 ). These genes may represent specific regional targets of FOXP2 regulation.
FOXP2 Targets in Lung versus Brain
Murine Foxp2 has been shown to repress the promoter of the human lung-epithelial specific gene SP-C in vitro. 12 Since Foxp2 has been reported as a transcriptional repressor that is expressed in the developing lung of mice, 12 we were interested to see, which, if any, of the identified targets were potentially more-specific targets in the developing brain relative to lung, a non-CNS tissue expressing high levels of FOXP2 during development. Furthermore, no studies of targets of FOXP2 have been published from any human tissue, so even overlapping targets would be of general interest and would serve as a core set of nontissue-specific FOXP2-regulated genes. We performed ChIP-chip in human fetal lung at 18 GW and identified 192 targets (table 1) . There was 47% and 37% overlap between genes identified in lung and BG and in lung and IFC, respectively ( fig. 3 ), providing further confidence in these genes as robust FOXP2 targets. Subtraction of the lung-enriched genes from the CNS data sets yielded 84 BG-specific genes and 83 IFC-specific genes ( fig. 3 and table 1). In addition, there were eight targets found in both BG and IFC that were not enriched in lung. These highestconfidence brain-enriched targets include FGF8, which is a key effector of cortical patterning in mammals, 36 and HOXB5 and HOXB7, members of the homeobox family of transcription factors, many of which are already known to be involved in CNS patterning. 37, 38 To provide independent validation of the array results, we checked a cross-section of the putative FOXP2 targets by ChIP-PCR, as is now standard. 34, 35, 39, 40 We used a second commercial antibody to FOXP2 to validate brain tissue and an antibody against the FLAG epitope in a neuronal cell line. For the cell-line confirmation, the neuronal cell line SH-SY5Y was stably transfected with FOXP2 isoform I with three C-terminal FLAG tags (see the "Material and Methods" section). Using either real-time quantitative or semiquantitative PCR, we assessed seven nervous-system targets in vitro and were able to confirm enrichment of FOXP2 occupancy at the promoters of all these genes ( fig.  4 and data not shown) . In contrast, the promoter of one lung target tested, ANK1, was not pulled down in these neuronal cells and served as a negative control; even though the level of expression of ANK1 changed in SY5Y cells with overexpressed FOXP2, it is likely a result of indirect regulation by FOXP2 and not direct binding. Although tissue was a limiting factor, we were able to test a subset of FOXP2 CNS targets in fetal brain tissue by ChIP-PCR and confirmed three of five promoters examined, providing a secondary level of confirmation for these targets ( fig. 4 and data not shown) .
In Vitro Functional Validation of FOXP2 Targets
To provide some functional evidence of target regulation, we assessed the effect of FOXP2 overexpression in a neuronal cell culture system on identified FOXP2 targets. SH-SY5Y cells were stably transfected with FOXP2 isoform I with three C-terminal FLAG tags, and a population of stably transfected cells was used for the experiments at several different passages ( fig. 5 ). Cells stably transfected with empty plasmid were used as a baseline control for comparison. Immunoblotting of the two cell lines for both FOXP2 and FLAG revealed robust expression of FLAGtagged FOXP2 in the cell line transfected with FOXP2, compared with no expression in the cells transduced with the empty vector ( fig. 5A and data not shown). This cell line provides an appropriate vehicle for overexpression studies, since FOXP1 is natively expressed in these cells, whereas FOXP2 is not detectable. , by Student's t test).
The majority of target genes investigated were chosen randomly, although a few were selected on the basis of their enrichment in all tissues studied (NOS1, CALCRL, PM5, and GDF5). Real-time quantitative RT-PCR (qRT-PCR) for 19 genes was performed on seven biological replicates of both control cells and cells overexpressing FOXP2. qRT-PCR analysis demonstrated that the majority of FOXP2 target genes identified (11 of 19) had at least a 25% change in expression with FOXP2 isoform I overexpression ( fig. 5 ). Three genes, TAGLN, CALCRL, and CER1, showed up-regulation after overexpression of FOXP2, whereas DPAGT1 showed a trend toward increased expression ( fig. 5) . To test the reproducibility of the results, two genes, TNN1 and NUDT1, were examined using two different sets of primers in a blinded fashion. Both primer sets gave very similar results for each gene, indicating high specificity for the assay (data not shown). By use of a twotailed paired t test, five of the genes had statistically significant fold changes between control and FOXP2-overexpressing cells. These genes were CALCRL, NOS1, LBR, KCNJ15, and ANK1. Accordingly, all these genes had changes 11.5 fold and were contained within the topseven most changed genes. Interestingly, two of these genes, NOS1 and CALCRL, represent two of the genes enriched in all tissues by ChIP-chip and, as mentioned above, were selected a priori for this reason. Thus, we can conclude that the levels of at least 26% of the genes identified as targets of FOXP2 can be altered by manipulating expression of FOXP2 in a neuronal cell line. These data, confirming slightly more than 25% of targets examined in vitro, are consistent with those of other published studies, in which 20%-35% of the targets are typically confirmed in this manner.
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FOXP2 Binding Sites Sequence in Candidate Genes
We next determined whether the promoter regions of candidate genes present on the Aviva array contain putative FOXP2 binding sites. Since double-stranded PCR products were spotted onto the array, the binding site could lie in either strand, so we examined both strands. We inspected the sequences of identified candidate targets for the FOXP2 binding site CAAATT or the core FOXP2 binding site AAAT. 44 The sequence from 323 of 367 potential targets identified by ChIP-chip was examined for binding sites, and 95% (307 genes) were found to contain at least one AAAT core FOXP2 binding site, whereas 106 contained at least one CAAATT binding site (table 1) . Since the FOXP1 binding site (TATTT[A/G]T) has been shown to be a possible FOXP2 binding site, 4, 45 we also searched for the presence of a FOXP1 binding site. A total of 82 genes were found to have at least one FOXP1 binding site (table 1). All genes tested by overexpression of FOXP2 were found to have at least one copy of the core-binding site (AAAT), and most had multiple sites. HSPB7, CER1, CALCRL, ANK1, LBR, and KCNJ15, which showed directional changes in expression following overexpression of FOXP2, were also found to have at least one CAAATT binding site. Additionally, NOS1, which showed a large, statistically significant decrease in expression, and CALCRL, which showed a significant increase in expression after FOXP2 overexpression, as well as GDF5, were found to have a FOXP1 binding site present. Comparing this enrichment of FOXP2 sites within the target genes identified on the array with an equivalent number of random promoter sequences from Ref Seq genes showed a statistically significant enrichment for all sequences identified in BG as a group ( , by x 2 with Yates correction), which was P ! .05 more significant for the more stringent canonical CAAATT site in BG targets ( , by x 2 ). The targets identified P p .007 Figure 6 . GO categories of in vivo targets, revealing tissue specificity of target pathways. FOXP2 target gene lists from either the CNS (BG and IFC) or lung were analyzed for significantly enriched GO categories by use of DAVID Bioinformatics Resources. Categories were considered significantly enriched if at least three genes were in one category with a P value р.05. Significant CNS targets with a known molecular function fall into six categories (A), whereas lung targets can be classified into three categories (B), none of which overlap with the CNS results. Significant CNS targets with a known biological function are grouped into 11 categories (C). There were no significant biological function categories for lung-specific targets.
in IFC and lung showed the same trend as BG but did not reach significance.
Functional Annotation
To investigate whether FOXP2 target genes belong to functional categories that provide insight into the role of FOXP2, we performed GO and pathway analysis on target genes, using the DAVID Bioinformatics Resources. 24 Gene targets identified in BG or IFC were grouped together as "CNS-specific" genes and were compared with and contrasted to "lung-specific" genes. We focused on GO categories of level three or higher, containing at least three genes and having a P value р.05 by Fisher's exact test. CNS-specific genes were significantly enriched in six categories of molecular function, and the lung genes were enriched in three categories that did not overlap with those found in the CNS gene set ( fig. 6 ). The CNS-specific genes were enriched for 11 biological-function GO categories, whereas the lung data set did not have any significant categories grouped according to biological function.
Several intriguing CNS-enriched GO categories were 46, 47 and RPS6KA2, also known as RSK3, which is highly expressed in the cortical primordium. 48 Mutations in a related family member of RSK3, RSK2, lead to CoffinLowry syndrome (MIM 303600), which is associated with cognitive abnormalities. 49 Another critical pathway downstream of FOXP2 in the IFC appears to be neurite outgrowth and axonal morphology, including calcium-mediated growth cone dynamics (e.g., GALR2, POU4F2, RRAS, and RYR3). [50] [51] [52] [53] [54] Further support for the role of FOXP2 transcriptional targets in dynamic regulation of neuronal structure was obtained NOTE.-Estimated rates of protein-sequence divergence between humans and chimpanzees were obtained from the study by Khaitovich et al. 29 NA p not available.
Table 3. Summary of Evolutionary Data
The 
Possible Positive Selection of Several FOXP2 Targets in Humans
FOXP2 is clearly involved in multiple functions not related to human higher cognitive functions, including sensorimotor integration and vocal learning in birds 8, 55 and lung development outside the CNS. 12 It would therefore be useful to identify a list of targets that most likely contribute to the development of higher cognitive specializations. 11 We hypothesized that, given the genetic complexity of a highly advantageous trait such as human language, positive selection may be working on FOXP2 target proteins in addition to FOXP2 itself. 17, 18 We reasoned that identification of FOXP2 target genes potentially under positive selection will enrich for those target genes more likely to be involved in language development. We analyzed our data with respect to published estimates of protein sequence divergence (Ka/Ki and Ka/ Ks) for 1,168 genes with available data. 29 Ka measures the rate of nonsynonymous nucleotide substitutions, Ki measures the rate of nucleotide substitutions in interspersed repeats within a 250-kb window centered around each gene, and Ks measures the rate of synonymous substitutions. Low Ka/Ki or Ka/Ks values suggest strong purifying selection (deleterious mutations), whereas elevated Ka/Ki values suggest accelerated evolution via positive selection, or relaxation of constraint. 29 Typically, a value 11.0 is indicative of acceleration. 56 Fourteen genes identified as FOXP2 targets in either BG, IFC, or lung had Ka/Ks or Ka/Ki 11.0 (table 2) . As a whole, these genes are potential key FOXP2 targets that, by virtue of their sequence divergence, show evidence of accelerated evolution. Remarkably, this list includes genes such as NDUFA2, which is part of the electron transport chain, a pathway identified to be under potential adaptive evolution in humans by comparative gene-expression studies in brain. 57, 58 It also includes a number of other genes implicated in vertebrate forebrain patterning, including HESX1 and CER1. Remarkably, four of the FOXP2 targets, HESX5, MEOX1, PIR51, and RBP2, have Ka/Ks values 150.
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Genes with evidence of accelerated evolution, which is likely to be indicative of positive selection in humans, comprise a key cohort potentially related to human cognitive specializations integrated by the BG and IFC, including speech and language.
Differential Expression of Several FOXP2 Targets between Chimpanzee and Human Brain
Although measures of protein-sequence divergence measure one key metric of function relevant to evolution, they do not consider additional changes in promoter or other regions that might alter gene expression, another dimension relevant to brain evolution. 58, 59 This is especially important because FOXP2 is a transcriptional regulator, and one might expect its targets to exhibit differential expression between evolutionarily divergent species. Therefore, we performed a meta-analysis of primate-human gene-expression data, to identify genes differentially expressed in the brains of humans and nonhuman primates, using three published data sets [26] [27] [28] to insure identification of the most robust changes in expression (see the "Material and Methods" section). This was essential since each study was comprised of only a few individuals. We identified 47 FOXP2 target genes that were differentially expressed between human and chimpanzee brains, including one of the genes whose coding region was also under positive selection, FCGR2 (table 3) .
Among FOXP2 in vivo targets showing primate-human differential expression were a number of genes encoding transcription factors involved in neural development, including PAX3 and HOXB5, and a number of other genes encoding known CNS patterning and guidance molecules, such as EPHX2, ITGB3, and SEMA3B. 60 Several genes related to neural transmission, including neurotransmitter receptor genes GFRA1 and GRIK1, were also identified among this cohort. When combined with the analysis of sequence evolution, these data suggest a potential role of specific genes in human cognition by identifying genes with differential expression at the mRNA level or that are potentially under positive selection in humans.
Discussion
Here, we identify FOXP2 targets in vivo for the first time, providing an initial transcriptional network downstream of this gene known to be involved in human higher cognition and vocal-motor learning. We used previously published, well-validated ChIP-chip methods 21, 22 and, in addition, performed extensive functional validation. Although the majority of genes were repressed by FOXP2, we were able to identify a subset of genes that appear to be activated by FOXP2 at the transcriptional level, indicating that FOXP2 can act as a transcriptional activator in some contexts. Further, we show that some of the genes show evidence of accelerated evolution and thus may be under positive selection in humans, or they are differentially expressed between chimpanzee and human brain, providing support for their potential role in higher cognition and language. Some FOXP2 targets, such as FGF8 and PAX3, have known roles in cerebral cortical patterning, immediately connecting FOXP2 transcriptional regulation to brain patterning during development.
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FOXP2 Targets and Transcriptional Activity
FOXP2 promoter binding demonstrated by ChIP-chip across multiple samples and multiple independent replicate experiments provides strong support for the targets identified. By comparing targets identified in different CNS tissues, we were able to identify a large set of core nervous-system targets with genes specific to the different regions. Further, we confirm a cross-section of targets, using ChIP-PCR in vitro and in vivo with use of a second antibody, an additional level of confirmation.
We also note that a subset of FOXP2 targets were identified in two brain regions and not in lung. Although we hypothesize that some of these may be CNS-specific FOXP2 targets, it remains possible that some could be targets in other nonneural tissues, a question that can be explored in subsequent studies. Additionally, this distinction of CNS specificity does not necessarily make these genes higher priorities for further study than genes identified in lung. Many FOXP2 targets were also identified in the lung, including several genes known to play important roles in nervous-system development or maturation, such as MEF2D, GDF5, POU4F3, SEMA3B, A2BP1, and PAX3, which is correlative to the key function of FOXP2 in both lung and brain development.
It is also supportive that we identified consensus sites described elsewhere on the basis of the binding structure of FOXP2 44 in a majority of the FOXP2 target genes. Statistical analysis supports the enrichment of putative FOXP2 binding sites within the target genes identified in BG. However, there was only a trend toward significance in frontal cortex and lung, and not all candidate genes identified have a consensus binding sequence, suggesting that other as-yet unidentified FOXP2 regulatory regions exist in these genes or that FOXP2 may act in a complex that permits binding to different sites. These results indicate the need for further investigation into the sequence-specific DNA binding parameters of FOXP2.
Here, we took an additional validation step by showing that 125% of genes whose promoters were bound by FOXP2 protein were indeed regulated by manipulation of FOXP2 levels in a neuronal cell line. Since the basic ChIP experiment was done in tissue, and it was necessary to perform functional confirmation in vitro, the cell line is distinct from the original in vivo tissue; yet, we were still able to confirm transactivation in a percentage of targets very similar to that in other published studies. 39, 40, 42, 43 We were able to show that, in general, overexpression of FOXP2 resulted in the expected decrease in expression of target genes. However, overexpression of FOXP2 increased expression of TAGLN, CALCRL, and CER1, suggesting transcriptional activation. This, along with the study by Vernes et al., 19 (in this issue) provides the first evidence that FOXP2 can potentially act as a transcriptional activator in certain situations. ChIP-chip identifies promoter regions that are bound to FOXP2 but does not indicate more-complex transcriptional regulation that may have tissue-and cellspecific requirements for regulating transcription. Thus, the behavior of the subset of genes not altered after forced FOXP2 overexpression may be attributed to the lack of additional binding partners necessary for FOXP2 transcriptional regulation of certain genes. However, we do expect a percentage of false-positive results contained within our subset of genes.
Using a similar experimental paradigm, Vernes et al. CALCRL primer pairs on our respective cDNA. The results were consistent across primer pairs in each cell line and therefore are not due to testing distinct isoforms (data not shown). Many factors could explain these differences between the studies. For example, variations in the levels of FOXP2 expression in each of the cell lines used could explain these discrepancies. SH-SY5Y cells also contain abundant amounts of FOXP1 protein, and it is possible that FOXP2 and FOXP1 share a subset of common transcriptional targets. FOXP2 has been shown to heterodimerize with FOXP1, 13 and heterodimers of FOXP2 with FOXP1 may result in different transcriptional outcomes than homodimers of FOXP2 or FOXP1. Thus, one could imagine a scenario in which low levels of FOXP2 repress transcription through heterodimerization with FOXP1, but, with increasing amounts of FOXP2, there is competition of FOXP2 homodimers with endogenous FOXP1, leading to transcriptional activation. Thus, as has been the case with other transcription factors, it will be important to define a subset of genes coregulated by FOXP2 and FOXP1, as well as the repertoire of FOXP2 partners and their regulation, to understand the context in which FOXP2 acts as a transcriptional repressor or activator.
Function of Targets
The target genes identified provide a foundation for exploring the transcriptional network downstream of FOXP2 in the developing brain. Functions such as growth regulation, embryonic development, and signal transduction identified as enriched GO categories for the candidate targets of FOXP2 are also common functions for targets of other forkhead-containing genes. [62] [63] [64] GO analysis of the potential targets specific to IFC indicated that many of these genes are involved in growth and morphogenesis, whereas other classes, such as development, were enriched for in targets identified in BG, indicating different downstream functional differences in the different regions of the brain. Furthermore, FOXP2 continues to be expressed in the adult and is modulated by vocal learning in adult song birds. 55 Thus, the identification of FOXP2 target genes involved in neurite outgrowth, calcium signaling, and learning, by Ingenuity pathway analysis, may provide a potential molecular link to ongoing behavioral plasticity throughout development and into adulthood.
Previous work has suggested that FOXP2 may be under positive selection in humans, so we reasoned that some FOXP2 targets may be components of neurodevelopmental pathways also under positive selection. 17, 18 Large-scale gene coexpression network analysis of human and chimpanzee brain confirmed the previously reported action of positive selection on the pathway of the electron transport chain. 57, [65] [66] [67] Further, this work showed that entire functional modules of coexpressed genes appear to be under positive selection in humans. 65 Other genomewide analyses investigating alleles with accelerated increase of frequency between three different human populations have demonstrated that multiple genes in the phosphatidylinositol pathway, in addition to the electron transport chain pathway, have undergone positive selection. 68 These precedents support the notion that positive selection of genes regulated by FOXP2 may direct us to molecular pathways of particular interest in human evolution and human cognitive specialization, since language is a complex trait that likely can be modulated by many genes. 11 Some of the FOXP2 target genes that we identified are genes known to be involved in human brain development and patterning, such as EFNB3, HESX1, and CER1. This provides further support for the notion that targets of FOXP2 showing these significant differences between humans and our closest relative, the chimpanzee, are particularly important in development of human cognitive specializations.
Similarly, 15 of the potential FOXP2 targets identified here (APOD, 69 91 and ZNF74 92 ) have shown some evidence of association with schizophrenia (SCZD [MIM 181500]), a disease that has been suggested to involve primary language dysfunction. Although most of these associations are preliminary or marginal, DISC1 has been clearly replicated. The association of SNP rs2396753, located within an intron of FOXP2, with schizophrenia with auditory hallucinations, 93 further suggests that targets of FOXP2 may also be candidates for involvement in schizophrenia. The concept that complex genetic disorders might involve multiple genes within common pathways implies that the FOXP2 targets identified here are realistic candidates for a variety of neurodevelopmental disorders involving higher cognitive functions.
In summary, these data are the first identification of human FOXP2 targets in the developing brain. This is also the first time, to our knowledge, that ChIP-chip has been used to assess transcription factor targets in the human fetal brain. Many of the identified FOXP2 targets have been previously characterized as having critical roles in several important neuronal features, such as neurite outgrowth and axon pathfinding. In addition, we have uncovered targets of FOXP2 that may have vital functions in the evolution of the mammalian brain. Since FOXP2 has a direct link to speech in humans, together these findings provide insight into signaling pathways that may be important both in the development and evolution of language.
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